Gyre Therapeutics Inc. (GYRE) — Cash Flow Reinvestment Rate
Gyre Therapeutics Inc. (GYRE) has a Cash Flow Reinvestment Rate of 0.41x as of September 2025, reinvesting $1.93 Million (capex $683.00K plus investments $-1.25 Million) from operating cash flow of $4.68 Million. Explore GYRE capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Cash Flow Reinvestment Rate (2007–2023)
Historical reinvestment intensity for Gyre Therapeutics Inc. across 4 annual periods. Also explore Gyre Therapeutics Inc. assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Gyre Therapeutics Inc. (2007–2023)
Year-by-year capital reinvestment analysis for Gyre Therapeutics Inc.. For live market cap and broader valuation context, see Gyre Therapeutics Inc. (GYRE) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.09x | $28.35 Million | $25.89 Million | $8.59 Million | ▼ -37.9% |
| 2022 | 1.76x | $18.81 Million | $10.68 Million | $5.00 Million | ▲ +7259.4% |
| 2010 | 0.02x | $3.31 Million | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $4.94 Million | $24.84 Million | $4.94 Million | — |